Dr. Fawad Khan

Dr. Fawad Khan, MBBS, is a Staff Physician at Cleveland Clinic Abu Dhabi. He serves as a Family Medicine Consultant, Medical Breast Specialist and High Risk Physician, who leads the Hereditary High-Risk and Longevity Medicine Programs within the Oncology Institute. He previously served as Chairman of the Primary Care department.

Dr. Khan completed Fellowship training in Medical Breast with a focus on Cancer Genomics from Cleveland Clinic Foundation, Ohio. In 2022, he spearheaded the Hereditary High-Risk Program at Cleveland Clinic Abu Dhabi, a unique program which focusses on populations at increased of cancers. These high-risk patients are then managed under a personalised Precision Prevention Program to reduce the risk of cancer, under a multi-disciplinary team of experts at Cleveland Clinic Abu Dhabi.

He also leads the Longevity Medicine Program which is designed to support cancer patients after their cancer treatment ends and to guide them through the next stage of their care.

Prior to joining Cleveland Clinic Abu Dhabi, Dr. Khan served as a Medical Director for Mediclinic Group. During his role over 4 years, he was responsible for 22 ambulatory multi-specialty centres across Abu Dhabi and Al Ain. He led a team of over 170 physicians and played an instrumental role in establishing a strong clinical governance structure across the network of clinics. Under his leadership he saw the introduction of practice guidelines, physician appraisal process and structured CME programs to support physicians to practice at the top of their license.

Prior to this, he served in the Primary Care Taskforce at the Department of Health and played a key role from conceptualising to implementation of the Primary Care Strategy across the emirate of Abu Dhabi. Before relocating to the UAE in 2013, he served in several leadership roles in the UK.

He lives in Abu Dhabi with his wife and two children and is an avid golfer.